- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 113,560 | 30.09.24 22:00:13 | -0,130 | -0,11% | 113,560 | 113,600 | 113,170 | 113,690 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 100,090 | 30.09.24 22:00:10 | +2,720 | +2,79% | 99,940 | 100,070 | 97,060 | 97,370 |
